| Literature DB >> 20953334 |
Daniel A Finan1, Howard Zisser, Lois Jovanovič, Wendy C Bevier, Dale E Seborg.
Abstract
Two levels of control are crucial to the robustness of an artificial β-cell, a medical device that would automatically regulate blood glucose levels in patients with type 1 diabetes. A low-level component would attempt to regulate blood glucose continuously, while a supervisory-level, or monitoring, component would detect underlying changes in the subject's glucose-insulin dynamics and take corrective actions accordingly. These underlying changes, or "faults," can include changes in insulin sensitivity, sensor problems, and insulin delivery problems, to name a few. A multivariate statistical monitoring technique, principal component analysis (PCA), has been applied to both simulated and experimental type 1 diabetes data. The objective of this study was to determine if PCA could be used to distinguish between normal patient data, and data for abnormal conditions that included a variety of "faults." The PCA results showed a high degree of accuracy; for data from nine type 1 diabetes subjects in ambulatory conditions, 33 of 37 total test days (89%), including fault days and normal days, were classified correctly. Thus, the proposed monitoring technique shows considerable promise for incorporation into an artificial β-cell.Entities:
Year: 2010 PMID: 20953334 PMCID: PMC2953258 DOI: 10.1021/ie901891c
Source DB: PubMed Journal: Ind Eng Chem Res ISSN: 0888-5885 Impact factor: 3.720